Nordic Capital has signed an agreement to acquire a majority share in IntegriChain, a leading provider of pharmaceutical technology, data, consulting, and outsourcing solutions designed to improve how life sciences products reach customers. IntegriChain delivers pharma’s only fully integrated platform for commercialization and market access, helping manufacturers bring their science to market while ensuring patients have affordable, timely, and sustainable access to therapy. Nordic Capital is acquiring the majority stake from Accel-KKR, a global software private equity firm, which first invested in IntegriChain in 2016.
Read the full article: Nordic Capital Acquires Majority Share in IntegriChain, the Only Fully Integrated Platform for Pharma Commercialization and Market Access //
Source: https://www.prnewswire.com/news-releases/nordic-capital-acquires-majority-share-in-integrichain-the-only-fully-integrated-platform-for-pharma-commercialization-and-market-access-301981627.html